This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Statistics and Research Methods  • Alert me on articles by topic

Mike Mitka

JAMA. 2005;293:2849.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As the new director of the National Heart, Lung, and Blood Institute (NHLBI), Elizabeth G. Nabel, MD, hopes to continue what she considers the important work already supported by the institute, while adding new approaches to keep the NHLBI on the cutting edge of scientific discovery.

Elizabeth G. Nabel, MD (Photo credit: National Heart, Lung, and Blood Institute/NIH)

"I’m very passionate about promoting biomedical research as well as new interventions and therapeutics that can benefit patients and public health," said Nabel, a cardiologist who served as the institute’s scientific director of Clinical Research before her appointment on February 1. She was also chief of the institute’s Vascular Biology Section, directing research on the molecular, cellular, and genetic mechanisms that cause vascular disorders.

Nabel’s predecessor, Claude Lenfant, MD, retired in 2003 after 22 years as director. Lenfant, who recruited Nabel to the institute in 1999, called her appointment "very . . . [Full Text of this Article]

SETTING PRIORITIES